Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
10.1002/oby.24229 7 DaniilopoulouI.VlachouE.LambrouG
This may result from metabolic adaptation, lifestyle factors, or dosing limitations
.webp?t=1743535811)
Bottom Line The Path to $1 Trillion Current State (Nov 2025): Stock Price: ~$990 Market Cap: ~$885-930B Distance to $1T: ~7-13% away Catalysts Ahead: Orforglipron approval (March 2026 expected) Continued GLP-1 market expansion Kisunla (Alzheimer's) adoption ramp Pipeline readouts in oncology and immunology For Long-Term Investors: Volatility is part of the journey
Many patients can successfully manage hair loss while continuing their medication by optimizing nutrition, slowing the rate of weight loss through dose adjustment, and adding hair-supportive treatments
US$ 20.34
US$ 29.31
US$ 25.48
US$ 29.63
US$ 21.65
